Agios Pharmaceuticals Inc PEG
Qual é o PEG de Agios Pharmaceuticals Inc?
O PEG de Agios Pharmaceuticals Inc é N/A
Qual é a definição de PEG?
A razão preço/lucro para crescimento (PEG) é o rácio P/L de uma ação dividido por uma taxa de crescimento prevista dos seus ganhos durante um período de 5 anos.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG de empresas na Setor Health Care em NASDAQ em comparação com Agios Pharmaceuticals Inc
O que Agios Pharmaceuticals Inc faz?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Empresas com peg semelhantes a Agios Pharmaceuticals Inc
- Yellow Pages tem PEG de N/A
- Antero Midstream Corp tem PEG de N/A
- Xenon Pharmaceuticals Inc tem PEG de N/A
- Mannkind Corp tem PEG de N/A
- Evolus Inc tem PEG de N/A
- Comscore tem PEG de N/A
- Agios Pharmaceuticals Inc tem PEG de N/A
- IRIDEX tem PEG de N/A
- Destination XL Inc tem PEG de N/A
- Kopin tem PEG de N/A
- Veru Inc tem PEG de N/A
- Punjab National Bank tem PEG de N/A
- Silk Road Medical Inc tem PEG de N/A